2 2
2 2
Risedronat
Risedronat
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Sandoz A/S. Risedronat Sandoz. Produktresumé. Läkemedelsverket [www]. [cited 2025-06-30].
UK Teratology Information Service (UKTIS). Use of Bisphosphonates in pregnancy. December 2022. Version 41. UKTIS [www]. [cited 2025-06-30].
Sokal A, Elefant E, Leturcq T, Beghin D, Mariette X, Seror R. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study. Osteoporos Int. 2019;30(1):221-229.
Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44(3):428-30.
- Sandoz A/S. Risedronat Sandoz. Produktresumé. Läkemedelsverket [www]. [cited 2025-06-30].
- UK Teratology Information Service (UKTIS). Use of Bisphosphonates in pregnancy. December 2022. Version 41. UKTIS [www]. [cited 2025-06-30].
- Sokal A, Elefant E, Leturcq T, Beghin D, Mariette X, Seror R. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study. Osteoporos Int. 2019;30(1):221-229.
- Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44(3):428-30.